A monotonic and prognostic genomic signature from fibroblasts for colorectal cancer initiation, progression, and metastasis
Mol Cancer Res. 2014 Sep;12(9):1254-66. doi: 10.1158/1541-7786.MCR-14-0121.…
Lymphoma-directed conditioning for aggressive lymphoma
Lancet Oncol. 2014 Jun;15(7):678-9. doi: 10.1016/S1470-2045(14)70232-3.…
Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy
Cancer Cell. 2014 May 12;25(5):638-651. doi: 10.1016/j.ccr.2014.03.017.ABSTRACTTo…
The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis
Pharmacogenomics J. 2014 Oct;14(5):424-31. doi: 10.1038/tpj.2014.16.…
Linkage of DNA methylation quantitative trait loci to human cancer risk
Cell Rep. 2014 Apr 24;7(2):331-338. doi: 10.1016/j.celrep.2014.03.016.…
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect
Nat Commun. 2014 Apr 3;5:3608. doi: 10.1038/ncomms4608.ABSTRACTCancer…
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect
Nat Commun. 2014 Apr 3;5:3608. doi: 10.1038/ncomms4608.ABSTRACTCancer…
PKA signaling drives mammary tumorigenesis through Src
Oncogene. 2015 Feb 26;34(9):1160-73. doi: 10.1038/onc.2014.41.…
Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation
Bone Marrow Transplant. 2014 Jun;49(6):744-50. doi: 10.1038/bmt.2014.55.…
Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors
Oncotarget. 2014 May 30;5(10):3023-8. doi: 10.18632/oncotarget.1814.ABSTRACTPARP…
Tubers from patients with tuberous sclerosis complex are characterized by changes in microtubule biology through ROCK2 signalling
J Pathol. 2014 Jul;233(3):247-57. doi: 10.1002/path.4343. Epub…
Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer
Mol Cancer. 2014 Mar 5;13:46. doi: 10.1186/1476-4598-13-46.ABSTRACTBACKGROUND:…
